Manufacturer Pulls Darvon, Darvocet; FDA Wants Generic Makers to Do the Same

The U.S. Food and Drug Administration announced Friday that it is pulling off the U.S. market the prescription painkillers Darvon and Darvocet, which combines Darvon with the aspirin substitute acetaminophen, because of new scientific evidence they can damage the heart, even at recommended doses, or cause fatal cardiac abnormalities. The manufacturer, Xanodyne Pharmaceuticals Inc. of Newport, Ky., agreed to withdraw the two brand-name drugs. The agency now is asking manufacturers of generic...Full Story
Commenting on this article is closed.